NVDA gained a massive 197% since our AI first added it in November - is it time to sell? 🤔Read more

Why Jabil Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Published 20/06/2024, 18:26
© Reuters.  Why Jabil Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Thursday\'s Mid-Day Session
JBL
-

Benzinga - by Avi Kapoor, Benzinga Staff Writer.

Shares of Jabil Inc. (NYSE:JBL) fell sharply during Thursday's session following third-quarter results.

Jabil reported third-quarter fiscal 2024 revenue of $6.77 billion, down by 20.2% year-on-year, beating the analyst consensus estimate of $6.53 billion. The print manufacturing company's adjusted EPS of $1.89 beat the analyst consensus of $1.85, according to data from Benzinga Pro.

Jabil said it expects fourth-quarter revenue of $6.3 billion – $6.9 billion (consensus: $6.8 billion) and adjusted EPS to $2.03 – $2.43 (consensus: $2.22).

Jabil shares dipped 7.8% to $116.37 on Thursday.

Here are some other stocks moving in today’s mid-day session.

Gainers

  • MGO Global, Inc. (NASDAQ:MGOL) shares jumped 222.8% to $1.48 after the company said it expects the pending acquisition of Spetner Associates to close in the second half of 2024, projecting it to increase annualized revenue to approximately $28 million.
  • Griid Infrastructure Inc. (NASDAQ:GRDI) climbed 89.3% to $1.48 after falling more than 10% on Tuesday.
  • Zapp Electric Vehicles Group Limited (NASDAQ:ZAPP) gained 89% to $2.58 after the company said it expects first customer deliveries of the i300 in the fourth quarter and anticipates selling over 5,000 units in the fiscal year ending September 30, 2025.
  • Reliance Global Group, Inc. (NASDAQ:RELI) shares climbed 60.5% to $0.6279. Reliance Global Group announced major enhancement of capital structure following cashless exercise of warrants.
  • Allurion Technologies Inc. (NYSE:ALUR) gained 50% to $1.598. Allurion announced publication of new data demonstrating lean mass gains in patients experiencing 14% weight loss.
  • SMX (Security Matters) Public Limited Company (NASDAQ:SMX) rose 43% to $0.1702 after jumping 19% on Tuesday.
  • Soluna Holdings, Inc. (NASDAQ:SLNH) gained 23.3% to $5.96.
  • Femasys Inc. (NASDAQ:FEMY) rose 22% to $1.1650 after receiving CE Mark approval from the EU MDR for its FemaSeed, FemVue, FemCerv, and FemCath products.
  • Molecular Partners AG (NASDAQ:MOLN) shares rose 21.1% to $9.63 after gaining 9% on Tuesday.
  • Surf Air Mobility Inc. (NASDAQ:SRFM) jumped 20.6% to $0.3850.
  • ToughBuilt Industries, Inc. (NASDAQ:TBLT) gained 20.2% to $3.75.
  • MicroCloud Hologram Inc. (NASDAQ:HOLO) surged 19.7% to $1.1303. MicroCloud Hologram entered into convertible note purchase agreements with investors for $28 million on June 18.
  • Presto Automation Inc. (NASDAQ:PRST) shares climbed 19.2% to $0.0877after falling around 5% on Tuesday.
  • NanoViricides, Inc. (NASDAQ:NNVC) gained 16.5% to $1.91. Nanoviricides reported that the ultra-broad-spectrum antiviral NV-387, a Phase 2 Stage drug candidate, was found to be effective in protecting lungs from damage in a lethally infected influenza H3N2 mouse model.
  • Lobo EV Technologies Ltd. (NASDAQ:LOBO) rose 16.4% to $2.47.
  • Ocular Therapeutix, Inc. (NASDAQ:OCUL) gained 16% to $6.36 after TD Cowen upgraded the stock from Hold to Buy and raised its price target from $7 to $11.
  • Applied Digital Corporation (NASDAQ:APLD) jumped 15.3% to $5.95.
  • Ranpak Holdings Corp. (NYSE:PACK) climbed 13.7% to $6.49.
  • ImmunityBio, Inc. (NASDAQ:IBRX) rose 13.6% to $7.08 after the company announced insurance coverage of ANKTIVA across multiple states with first commercial doses administered.
  • Harrow, Inc. (NASDAQ:HROW) gained 12.2% to $19.81 after the company announced the manufacture of the first of three commercial-scale process performance qualification batches of TRIESENCE 40 mg/mL. Also the company announced that the second and third required PPQ batches are now scheduled.
  • ZKH Group Limited (NYSE:ZKH) rose 11.4% to $3.92
  • NANO Nuclear Energy Inc. (NASDAQ:NNE) gained 11.3% to $12.91.
  • Himax Technologies, Inc. (NASDAQ:HIMX) jumped 11.1% to $8.23
  • UTime Limited (NASDAQ:WTO) surged 11% to $0.5849
  • Nexalin Technology, Inc. (NASDAQ:NXL) gained 10% to $1.1450. Nexalin Technology shares jumped around 38% on Tuesday after the company was awarded a US patent on ‘Transcranial alternating current dynamic frequency stimulation (TACS) method for Alzheimers and Dementia.’
  • Bilibili Inc. (NASDAQ:BILI) shares climbed 7.8% to $17.45. On Tuesday, JP Morgan analyst Daniel Chen upgraded Bilibili from Neutral to Overweight and announced a $21 price target.
  • Super Micro Computer, Inc. (NASDAQ:SMCI) gained 7% to $982.60 after Elon Musk indicated the company will provide server racks for the supercomputer that xAI is building.
  • Advanced Micro Devices, Inc. (NASDAQ:AMD) rose 5% to $162.36.
Losers
  • Trevena, Inc. (NASDAQ:TRVN) fell 43.7% to $0.1993. Trevena announced preclinical TRV045 data for long-term analgestic effect in prelinical model of neuropathic pain. Also, the company announced TRV045 results provided director for additional NIH-initiated studies in epilepsy prevention and treatment.
  • Kaival Brands Innovations Group, Inc (NASDAQ:KAVL) shares declined 33.5% to $2.99 after gaining 8% on Tuesday.
  • Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) fell 29% to $1.10. Sonnet BioTherapeutics announced exercise of warrants for gross proceeds of $3.4 million.
  • Tempest Therapeutics, Inc. (NASDAQ:TPST) declined 25% to $2.1208. The company announced new data from the ongoing Phase 1b/2 clinical study on amezalpat2 (TPST-1120).
  • Nikola Corporation (NASDAQ:NKLA) declined 23.6% to $0.3672. Nikola announced 1-for-30 reverse stock split approved by board.
  • La Rosa Holdings Corp. (NASDAQ:LRHC) shares fell 23.5% to $1.37. La Rosa Holdings shares jumped 72% on Tuesday after the company entered a non-binding letter of intent to acquire a controlling interest in Red Door Title.
  • SYLA Technologies Co., Ltd. (NASDAQ:SYT) dipped 21.7% to $1.70.
  • Mustang Bio, Inc. (NASDAQ:MBIO) shares dipped 21% to $0.6721 after the company announced a $2.5 million registered direct offering of 6.130 million shares at $0.41 per share.
  • QXO, Inc. (NASDAQ:QXO) fell 20.9% to $72.55.
  • NLS Pharmaceutics AG (NASDAQ:NLSP) tumbled 20.3% to $0.1910 after jumping 82% on Tuesday.
  • DermTech, Inc. (NASDAQ:DMTK) fell 19.4% to $0.1176.
  • Dunxin Financial Holdings Limited (NASDAQ:DXF) shares fell 19.4% to $0.1728 after dipping 17% on Tuesday.
  • Tempus AI, Inc (NASDAQ:TEM) fell 15.1% to $25.76 amid post-IPO volatility.
  • Esperion Therapeutics, Inc. (NASDAQ:ESPR) declined 15% to $2.2991 after B of A Securities downgraded the stock from Neutral to Underperform.
  • SRIVARU Holding Limited (NASDAQ:SVMH) shares fell 13.7% to $0.2150. SRIVARU, last week, announced it will begin accepting paid reservations and bookings for its flagship product, the PRANA 2.0, on June 16th.
  • Actelis Networks, Inc. (NASDAQ:ASNS) fell 12.2% to $1.8602. Actelis Networks shares jumped 84% on Tuesday after the company announced an agreement to serve as Carahsoft’s public sector distributor.
  • Jasper Therapeutics, Inc. (NASDAQ:JSPR) declined 10.1% to $20.84. Jasper Therapeutics announced appointment of Svetlana Lucas Ph.D., to its Board of Directors.
  • GMS Inc. (NYSE:GMS) declined 6.5% to $84.02 after the company reported mixed fourth-quarter financial results.
  • Nayax Ltd. (NASDAQ:NYAX) fell 6.1% to $21.23.
  • Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) fell 5% to $6.03 after the company’s board determined that recent takeover proposals were not in its best interests.
Now Read This: This Skyworks Solutions Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.